HTA Manager

) sponsored publications Under the guidance of the Directors and Team Lead, manage RWE studies in migraine Oversee the...

Lugar: Tadworth, Surrey | 04/06/2026 23:06:22 PM | Salario: S/. £43.34 - 56.55 per hour | Empresa: TalentMark

Business Development Manager, Real World Evidence, EMEA

, Real World Evidence, EMEA IQVIA Real-World Evidence (RWE) teams work with clients to help them collect and leverage real... in driving the growth of IQVIA’s RWE business through proactive identification, engagement, and conversion of new BioPharma...

Lugar: London | 04/06/2026 17:06:08 PM | Salario: S/. No Especificado | Empresa: IQVIA

Manager - HTA, Value & Evidence

generation, and operational excellence. Key Responsibilities Manage real-world evidence (RWE) studies aligned to global... Experience in HEOR, RWE, or health services research within pharma, consulting, or academia (typically 2+ years...

Lugar: Tadworth, Surrey | 04/06/2026 17:06:22 PM | Salario: S/. £37.86 per hour | Empresa: SRG

Head Marketing & Communications

: Sanome is the reference clinical AI company, the name in every hospital conversation, every VC market map, every pharma RWE.... Turn user studies, PMS data, RWE outputs, publications, and regulatory milestones into credible, high-impact content. Every...

Lugar: London - Wales | 04/06/2026 17:06:01 PM | Salario: S/. £70000 - 90000 per year | Empresa: Sanome

Procurement Specialist

. Find your future with us. Overview: An exciting opportunity has come up to join the BDUK Rotary Wing Enterprise (RWE) Supply Chain... and collaborative working relationships with the RWE programme team. Required Basic Qualifications: Experience in a procurement...

Lugar: Bristol - Yeovil, Somerset | 03/06/2026 19:06:03 PM | Salario: S/. No Especificado | Empresa: Boeing

Director, Evidence Generation

, Pharmaceutics, Priority Disease Areas Expertise, Product Launches, Product Strategy, Real World Evidence (RWE), Regulatory...

Lugar: London | 31/05/2026 21:05:56 PM | Salario: S/. No Especificado | Empresa: Novartis